(Q51275732)

2 April 2018

title

Biomarkers for Alzheimer's: the sequel of an original model. (English)

1 reference

2 April 2018

1 reference

1

1 reference

2 April 2018

Kaj Blennow

series ordinal

2

object named as

Kaj Blennow

1 reference

2 April 2018

publication date

1 February 2013

1 reference

2 April 2018

published in

Lancet Neurology

1 reference

2 April 2018

volume

12

1 reference

2 April 2018

issue

2

1 reference

2 April 2018

page(s)

126-128

1 reference

2 April 2018

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

The pathological process underlying Alzheimer's disease in individuals under thirty

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

Cognitive reserve, presynaptic proteins and dementia in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

Norms for imaging markers of brain reserve

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

CSF markers for incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

CSF biomarkers predict a more malignant outcome in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

Injury markers predict time to dementia in subjects with MCI and amyloid pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970305-8

7 January 2021

10.1016/S1474-4422(12)70305-8

Identifiers

DOI

1 reference

2 April 2018

1 reference

2 April 2018